This article provides an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies.
This articles addresses pharmaceutical antitrust in Switzerland.
This article presents the views and observations of leading anti-corruption practitioners in jurisdictions spanning every region of the globe.
The substantial increase in international trade disputes, constraints on US courts, and the limited reach of US court judgments create a demand for an innovative way to handle international technology disputes.
The amendments to the pretrial discovery rules of the Federal Rules of Civil Procedure, enacted after almost five years of work, are supposed to clarify how to handle electronically stored information. Even the drafters acknowledged that the old discovery rules were not clear. However, the new rules are likely to stimulate a new breed of complex discovery dispute.
In this article, learn the more material changes brought about by the GDPR (those likely to have a bigger impact), comments on the likely impact of the proposal on businesses, and suggests action points that businesses can begin to address in the lead-up to the measure coming into force.
This is the outline for the session, Allocating Risk for Your Company: Playing the Feud.